AbbVie To Acquire Cerevel Therapeutics In $8.7 Bln Deal Stock Market Stocks to buy Stocks to sell admin December 7, 2023 0 90 1 minute read (RTTNews) – AbbVie Inc. (ABBV) agreed to acquire Cerevel Therapeutics (CERE) for $45.00 per share in cash, valuing the company at about $8.7 billion.